Weakness and drugs of ingredients of ceftazidime (a real world drug study)
Summary:
Weakness is found among people who take drugs with ingredients of ceftazidime, especially for people who are female, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 11,913 people who have side effects when taking drugs with ingredients of ceftazidime from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Ceftazidime, Ceftazidime for injection and dextrose injection, Ceftazidime in dextrose container, Ceptaz, Fortaz, Pentacef, Tazicef, Tazidime, Tazidime in plastic container.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
11,913 people reported to have side effects when taking drugs with ingredients of ceftazidime.
Among them, 380 people (3.19%) have Weakness
What is Weakness?
Weakness is found to be associated with 3,639 drugs and 6,617 conditions by eHealthMe. Check the latest studies of Weakness.
Number of reports submitted per year:
Time on drugs with ingredients of ceftazidime when people have Weakness *:
- < 1 month: 98.39 %
- 1 - 6 months: 1.6099999999999999 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Weakness when taking drugs with ingredients of ceftazidime *:
- female: 53.09 %
- male: 46.91 %
Age of people who have Weakness when taking drugs with ingredients of ceftazidime *:
- 0-1: 0.0 %
- 2-9: 3.02 %
- 10-19: 8.16 %
- 20-29: 3.32 %
- 30-39: 7.25 %
- 40-49: 8.46 %
- 50-59: 11.48 %
- 60+: 58.31 %
Conditions people have *:
You may use this to check any potential undetected conditions.
Other drugs people take *:
You may use this to check any potential interacting drugs.
Other side effects people have besides Weakness *:
You may use this to check any potential undetected side effects.
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
- Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Related studies
Drugs with ingredients of ceftazidime, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on ceftazidime. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Aortic Arteriosclerosis and drugs of ingredients of thalidomide - 3 seconds ago
- Drug interactions of Cinnamon and Tramadol - 3 seconds ago
- Could Effexor cause Infusion Related Reaction? - 3 seconds ago
- Drug interactions of Ketamine Hydrochloride and Alfenta - 4 seconds ago
- Could Arimidex cause Systemic Sclerosis? - 5 seconds ago
- Drug interactions of Estradiol and Atrovent Hfa - 9 seconds ago
- Diarrhea in Magnesium Glycinate, how severe and when it was recovered? - 9 seconds ago
- Could Cyclophosphamide cause Abdominal Pain Aggravated? - 9 seconds ago
- Stools - Watery in Magnesium Glycinate, how severe and when it was recovered? - 10 seconds ago
- Could Lantus cause Glucose Tolerance Impaired? - 10 seconds ago